Skip to main content

Table 1 Availability (%) of essential medicines and technologies for major NCDs at primary care facilities

From: Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS)

Disease Items & Definition Public Primary Private Primary
Urban
N = 257
Rural
N = 280
Total
N = 537
Urban
N = 277
Rural
N = 235
Total
N = 512
Availability (95% CI)
Diabetes mellitus Medicine - Available medicines for Diabetes are Metformin and Insulin. 21.0 (16.4–26.4) 20.4 (16.0–25.5) 20.7 (17.4–24.3) 62.1 (56.2–67.6) 57.0 (50.6–63.2) 59.8 (55.4–63.9)
Technologies - At least one of each technology related to Diabetes, including glucometer, glucostrips and urine strips, should be available at the facility. 47.5 (41.4–53.6) 52.9 (47.0–58.7) 50.3 (46.0–54.5) 87.4 (82.9–90.8) 79.6 (73.9–84.3) 83.8 (80.3–86.7)
Both Medicines & Technologies as defined above 10.9 (7.6–15.3) 14.3 (10.6–18.9) 12.7 (10.1–15.8) 59.6 (53.7–65.2) 51.9 (45.5–58.3) 56.1 (51.7–60.3)
Cardio-vascular diseases Medicine - Available medicines for Hypertension and CVDs are Aspirin, at least one ‘long acting calcium channel blocker, ACE inhibitor, or diuretic’ and at least one statin. 37.4 (31.6–43.5) 24.6 (19.9–30.0) 30.7 (27.0–34.8) 46.2 (40.4–52.1) 40.4 (34.3–46.8) 43.6 (39.3–47.9)
Technologies - At least one of each technology related to Hypertension and CVDs, including BP apparatus, weighing scale and height scale, stethoscope, should be available at the facility. 67.7 (61.7–73.2) 60.0 (54.1–65.6) 63.7 (59.5–67.9) 14.8 (11.1–19.5) 12.3 (8.7–17.2) 13.7 (11.0–16.9)
Both Medicines & Technologies as defined above 32.7 (27.2–38.7) 19.3 (15.1–24.3) 25.7 (22.2–29.6) 10.1 (7.1–14.3) 7.7 (4.9–11.8) 9.0 (6.8–11.8)
Chronic Respiratory Diseases Medicine - Available medicines for COPD are at least one Bronchodilator and a steroid inhalant. 15.6 (11.6–20.5) 13.9 (10.3–18.5) 14.7 (12.0–18.0) 59.9 (54.0–65.6) 52.8 (46.4–59.1) 56.6 (52.3–60.9)
Technologies - At least one ‘Stethoscope’, should be available at the facility for COPD. 99.2 (96.9–99.8) 99.3 (97.2–99.8) 99.3 (98.0–99.7) 90.3 (86.1–93.2) 87.2 (82.3–90.9) 88.9 (85.8–91.3)
Both Medicines & Technologies as defined above 15.6 (11.6–20.5) 13.9 (10.3–18.5) 14.7 (12.0–18.0) 57.0 (51.1–62.8) 51.5 (45.1–57.8) 54.5 (50.1–58.8)
All above NCDs Medicine - See above for disease-specific definitions 4.3 (2.4–7.6) 2.1 (1.0–4.7) 3.2 (2.0–5.0) 42.6 (36.9–48.5) 33.2 (27.4–39.5) 38.3 (34.2–42.6)
Technologies - See above for disease-specific definitions 38.1 (32.4–44.2) 38.2 (32.7–44.1) 38.2 (34.1–42.4) 14.8 (11.1–19.5) 11.5 (8.0–16.3) 13.3 (10.6–16.5)
Both Medicines & Technologies
Both as defined above
2.3 (1.0–5.1) 1.1 (0.3–3.3) 1.7 (0.9–3.2) 9.0 (6.2–13.0) 6.8 (4.2–10.8) 8.0 (5.9–10.7)